Find a Clinical Trial
Filter
PATH-2: PLS240
Hemodialysis access, Thyroid diseases
All genders
18-80
Recruiting now
Division of Nephrology
Dompe' Reparixin study
COVID-19
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
MLS-101-206
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology
AN2 EBO301 MAC Study
Mycobacterial disease
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Moderna mRNA 1273 study
COVID-19
All genders
0-12
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
R3R
Chronic kidney disease
All genders
12+
Recruiting now
Department of Medicine, Division of Nephrology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Letermovir for secondary prophylaxis for CMV disease in solid organ transplant recipients
Cytomegalovirus infection
All genders
18-75
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
LYS228 Pharmacokinetics for Complicated UTI
Urinary tract infections
All genders
18-85
Recruiting now
Department of Urology